signal/raiseTrack rounds
E

Eli Lilly

Focus: Healthtech & bio, HR & work

Eli Lilly took part in 3 of the startup funding rounds we tracked in 2026. By money raised, its biggest sectors were Healthtech & bio and HR & work. The largest was AdvanCell's $315m Series D+ round. The most recent was General Medicine's Series B round in October 2026.

Deployed as lead$0k
Rounds led0
Rounds joined3
Largest round$315m

Also invested (3)

General MedicineSeries B · Healthtech & bio · San Francisco · 6 Oct$120mThatchSeries C · HR & work · United States · 15 Sep$108mAdvanCellSeries D+ · Healthtech & bio · Brisbane · 15 Jul$315m

By sector

Healthtech & bio$435mHR & work$108m

By stage

Series B$120mSeries C$108mSeries D+$315m

Co-investors

Andreessen Horowitz2 roundsMatrix1 roundVXI Capital1 roundBoxGroup1 roundIndex Ventures1 roundGeneral Catalyst1 roundScale Venture Partners1 roundAvid Ventures1 roundQuiet Capital1 roundSemperVirens1 round